A research-informed clinical discussion for carefully selected patients—not a routine wellness prescription.
LONGEVITY & HEALTHY AGING / PRACTITIONER-GUIDED
Rapamycin for longevity
Sirolimus is an FDA-approved drug for specific medical uses, but longevity use remains off-label and does not yet have proven healthspan or lifespan benefit.Create account & prepare for review →Education now / no routine prescribing · A prescription is never guaranteed.
Compelling biology and limited human longevity evidence; meaningful uncertainty remains.
Prescription required; longevity use is off-label
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓The person understands the uncertainty
- ✓A licensed clinician accepts responsibility for risk review and monitoring
- ✓The plan does not displace proven prevention
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- →Infection, immune, wound-healing and metabolic risk
- →Medication interactions and vaccination context
- →Laboratory and adverse-effect monitoring plan
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !Can affect immune function, lipids, glucose, blood counts and wound healing.
- !Longevity dosing is not established.
- !This pathway must never imply guaranteed access or benefit.
ORIGINAL SOURCES